HbA1c lowering effect The results of the clinical trials demonstrated significantly greater reductions in A1C with liraglutide compared to exenatide, and both GLP-1 receptor agonists caused greater reductions than those observed with sitagliptin [7] Data regarding these four agents from published head-to-head studies suggest that Liraglutide may have the largest A1C lowering capability, followed by dulaglutide, exenatide once weekly and then exenatide twice daily ( Figure 5 ) [8-10] GLP-1 RA are associated with an A1c reduction of 0.5-1.5% which is greater than 0.5-1% from DPP4 inhibitors the in head to head Duration clinical trials [11]
Results PLB administration improves ovarian function in PCOS mice After successfully establishing a PCOS mouse model by DHEA injection and treating them with PLB, HE staining results (Fig
About this article Cite this article Zhang, Y., Wang, D., Si, X
PlexusDx serves all 50 states and makes medication affordable and accessible
An interesting clinical case that raises useful questions, but risks shifting the interpretive lens too abruptly